CA Stock MarketDetailed Quotes

BUX Biomark Diagnostics Inc

Watchlist
  • 0.200
  • 0.0000.00%
15min DelayTrading Dec 17 14:27 ET
18.18MMarket Cap-10.00P/E (TTM)

Biomark Diagnostics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
-8.97%38.35K
-3.61%38.31K
6.34%163.22K
0.15%39.81K
12.62%41.54K
2.85%42.13K
10.71%39.75K
249.38%153.49K
64.82%39.75K
86.14%36.89K
Operating revenue
-8.97%38.35K
-3.61%38.31K
6.34%163.22K
0.15%39.81K
12.62%41.54K
2.85%42.13K
10.71%39.75K
249.38%153.49K
64.82%39.75K
86.14%36.89K
Cost of revenue
Gross profit
Operating expense
142.32%569.18K
48.31%642.61K
-21.51%1.48M
-25.03%383.56K
4.87%428.19K
-56.41%234.89K
1.52%433.3K
30.31%1.89M
-28.65%511.64K
53.28%408.3K
Selling and administrative expenses
24.04%284.68K
114.94%347.24K
-24.71%721.97K
0.29%190.04K
-43.86%140.86K
-38.15%229.52K
9.58%161.55K
69.88%958.96K
-20.53%189.49K
120.27%250.93K
-General and administrative expense
24.04%284.68K
114.94%347.24K
-24.71%721.97K
0.29%190.04K
-43.86%140.86K
-38.15%229.52K
9.58%161.55K
69.88%958.96K
-20.53%189.49K
120.27%250.93K
Research and development costs
152.65%238.72K
14.09%182.16K
19.18%650.53K
-20.28%211.29K
209.15%185.11K
31.82%94.49K
6.98%159.65K
9.66%545.84K
-27.62%265.05K
-9.44%59.88K
Depreciation amortization depletion
-35.74%58.17K
-43.66%57.75K
1.81%393.17K
-1.84%100.85K
10.04%99.31K
-6.30%90.52K
6.10%102.5K
115.00%386.2K
-21.15%102.74K
104.44%90.25K
-Depreciation and amortization
-35.74%58.17K
-43.66%57.75K
1.81%393.17K
-1.84%100.85K
10.04%99.31K
-6.30%90.52K
6.10%102.5K
115.00%386.2K
-21.15%102.74K
104.44%90.25K
Other taxes
69.43%-59.15K
----
---193.49K
--0
--0
---193.49K
----
--0
--0
--0
Other operating expenses
237.34%46.76K
478.36%55.47K
-1,599.50%-92.25K
-159.94%-118.62K
-59.74%2.92K
2,557.45%13.86K
-71.39%9.59K
-102.65%-5.43K
-155.97%-45.63K
-82.80%7.26K
Operating profit
-175.38%-530.83K
-53.55%-604.3K
23.98%-1.32M
27.15%-343.76K
-4.10%-386.65K
61.28%-192.76K
-0.68%-393.55K
-23.45%-1.73M
31.91%-471.9K
-50.64%-371.42K
Net non-operating interest income (expenses)
10.20%-16.48K
25.01%-18.98K
-1.05%-111.31K
-60.70%-47.58K
9.93%-20.07K
38.86%-18.35K
10.43%-25.31K
-121.71%-110.15K
18.51%-29.61K
-130.86%-22.28K
Non-operating interest income
-97.40%92
----
4,787.34%3.86K
308.86%323
--0
--3.54K
----
--79
--79
--0
Non-operating interest expense
-24.30%16.57K
-25.01%18.98K
4.48%115.17K
61.36%47.91K
-9.93%20.07K
-27.07%21.88K
-10.43%25.31K
121.87%110.23K
-18.29%29.69K
130.86%22.28K
Other net income (expenses)
638
33
-41
646
Gain on sale of security
----
----
--638
--33
---41
--646
----
----
----
----
Income before tax
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
-53.26%-393.7K
Income tax
Earnings from equity interest net of tax
Net income
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
-53.26%-393.7K
Net income continuous operations
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
-53.26%-393.7K
Noncontrolling interests
Net income attributable to the company
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
-53.26%-393.7K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-160.05%-547.31K
-48.80%-623.28K
22.52%-1.43M
21.97%-391.31K
-3.32%-406.76K
60.13%-210.46K
0.07%-418.86K
-26.71%-1.84M
31.29%-501.51K
-53.26%-393.7K
Diluted earnings per share
-295.73%-0.01
0.00%-0.02
0.00%-0.02
0
0.00%-0.02
74.73%-0.0025
0.00%-0.02
0.00%-0.02
0
-463.06%-0.02
Basic earnings per share
-295.73%-0.01
0.00%-0.02
0.00%-0.02
0
0.00%-0.02
74.73%-0.0025
0.00%-0.02
0.00%-0.02
0
-463.06%-0.02
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue -8.97%38.35K-3.61%38.31K6.34%163.22K0.15%39.81K12.62%41.54K2.85%42.13K10.71%39.75K249.38%153.49K64.82%39.75K86.14%36.89K
Operating revenue -8.97%38.35K-3.61%38.31K6.34%163.22K0.15%39.81K12.62%41.54K2.85%42.13K10.71%39.75K249.38%153.49K64.82%39.75K86.14%36.89K
Cost of revenue
Gross profit
Operating expense 142.32%569.18K48.31%642.61K-21.51%1.48M-25.03%383.56K4.87%428.19K-56.41%234.89K1.52%433.3K30.31%1.89M-28.65%511.64K53.28%408.3K
Selling and administrative expenses 24.04%284.68K114.94%347.24K-24.71%721.97K0.29%190.04K-43.86%140.86K-38.15%229.52K9.58%161.55K69.88%958.96K-20.53%189.49K120.27%250.93K
-General and administrative expense 24.04%284.68K114.94%347.24K-24.71%721.97K0.29%190.04K-43.86%140.86K-38.15%229.52K9.58%161.55K69.88%958.96K-20.53%189.49K120.27%250.93K
Research and development costs 152.65%238.72K14.09%182.16K19.18%650.53K-20.28%211.29K209.15%185.11K31.82%94.49K6.98%159.65K9.66%545.84K-27.62%265.05K-9.44%59.88K
Depreciation amortization depletion -35.74%58.17K-43.66%57.75K1.81%393.17K-1.84%100.85K10.04%99.31K-6.30%90.52K6.10%102.5K115.00%386.2K-21.15%102.74K104.44%90.25K
-Depreciation and amortization -35.74%58.17K-43.66%57.75K1.81%393.17K-1.84%100.85K10.04%99.31K-6.30%90.52K6.10%102.5K115.00%386.2K-21.15%102.74K104.44%90.25K
Other taxes 69.43%-59.15K-------193.49K--0--0---193.49K------0--0--0
Other operating expenses 237.34%46.76K478.36%55.47K-1,599.50%-92.25K-159.94%-118.62K-59.74%2.92K2,557.45%13.86K-71.39%9.59K-102.65%-5.43K-155.97%-45.63K-82.80%7.26K
Operating profit -175.38%-530.83K-53.55%-604.3K23.98%-1.32M27.15%-343.76K-4.10%-386.65K61.28%-192.76K-0.68%-393.55K-23.45%-1.73M31.91%-471.9K-50.64%-371.42K
Net non-operating interest income (expenses) 10.20%-16.48K25.01%-18.98K-1.05%-111.31K-60.70%-47.58K9.93%-20.07K38.86%-18.35K10.43%-25.31K-121.71%-110.15K18.51%-29.61K-130.86%-22.28K
Non-operating interest income -97.40%92----4,787.34%3.86K308.86%323--0--3.54K------79--79--0
Non-operating interest expense -24.30%16.57K-25.01%18.98K4.48%115.17K61.36%47.91K-9.93%20.07K-27.07%21.88K-10.43%25.31K121.87%110.23K-18.29%29.69K130.86%22.28K
Other net income (expenses) 63833-41646
Gain on sale of security ----------638--33---41--646----------------
Income before tax -160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K-53.26%-393.7K
Income tax
Earnings from equity interest net of tax
Net income -160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K-53.26%-393.7K
Net income continuous operations -160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K-53.26%-393.7K
Noncontrolling interests
Net income attributable to the company -160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K-53.26%-393.7K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -160.05%-547.31K-48.80%-623.28K22.52%-1.43M21.97%-391.31K-3.32%-406.76K60.13%-210.46K0.07%-418.86K-26.71%-1.84M31.29%-501.51K-53.26%-393.7K
Diluted earnings per share -295.73%-0.010.00%-0.020.00%-0.0200.00%-0.0274.73%-0.00250.00%-0.020.00%-0.020-463.06%-0.02
Basic earnings per share -295.73%-0.010.00%-0.020.00%-0.0200.00%-0.0274.73%-0.00250.00%-0.020.00%-0.020-463.06%-0.02
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.